Millions of women have given preference to the use of combined oral contraceptives (COCs)
since its introduction in the 1960s. Both oestrogens and progestogens can regulate …

Most up-to-date information on oral contraceptives (OCs) and breast cancer risk comes from
a collaborative re-analysis of individual data on 53 297 cases and 100 239 controls. It is now …

The following review considers epidemiological data published from 1990 onwards on oral
contraceptives (OCs) and the risk of cancers of the breast, cervix uteri, endometrium, ovary …

Combined oral contraceptives (COCs) are among the most widely used effective and
reversible means of family planning. Their beneficial effects are well documented, but many …

Extensive research during the last 20 years has shown that oral contraceptives are safe.
Several recent epidemiological studies have confirmed that combined oral contraceptives …

Results The risk of breast cancer increased with the duration of oral contraceptive use (p for
trend p= 0.002), while risk of ovarian and endometrial cancer decreased (p for trend p= 0.03 …

Oral contraceptives (OC) convey a protection against ovarian, endometrial and perhaps
colorectal cancer. However, OC use is associated with excess risk of breast, cervical and …

COCs (combined oral contraceptives) remain the most widely used effective and reversible
means of family planning. Their beneficial effects are well documented, but many questions …

Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence
Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted …

Background This analysis provides the final results on cancer incidence in relation to oral
contraceptive (OC) use from the Oxford–Family Planning Association (Oxford-FPA) …